Login
$GRC
$75.40 +$0.44 (0.59%) Close

Consolidated Balance Sheets

In millions of USD, except per-share amounts
Q3 FY2026
As of Sep 30, 2026
Q2 FY2026
As of Jun 30, 2026
Q1 FY2026
As of Mar 31, 2026
Q4 FY2025
As of Dec 31, 2025
Q3 FY2025
As of Sep 30, 2025
Q2 FY2025
As of Jun 30, 2025
Q1 FY2025
As of Mar 31, 2025
Q4 FY2024
As of Dec 31, 2024
Q3 FY2024
As of Sep 30, 2024
Q2 FY2024
As of Jun 30, 2024
Q1 FY2024
As of Mar 31, 2024
Q4 FY2023
As of Dec 31, 2023
Q3 FY2023
As of Sep 30, 2023
Q2 FY2023
As of Jun 30, 2023
Q4 FY2022
As of Dec 31, 2022
Q3 FY2022
As of Sep 30, 2022
Q2 FY2022
As of Jun 30, 2022
Q1 FY2022
As of Mar 31, 2022
Q4 FY2021
As of Dec 31, 2021
Current assets:
Cash and cash equivalents
Accounts receivable, net
Inventories, net
Prepaid and other
Total current assets
Property, plant and equipment, net
Other assets
Other intangible assets, net
Goodwill
Total assets
Current liabilities:
Accounts payable
Payroll and employee related liabilities
Commissions payable
Deferred revenue and customer deposits
Current portion of long-term debt
Accrued expenses
Total current liabilities
Pension benefits
Postretirement benefits
Long-term debt, net of current portion
Other long-term liabilities
Total liabilities
us-gaap_CommonStockNoParValue
Common shares, without par value: Authorized - 35,000,000 shares; Outstanding - 26,410,243 shares at September 30, 2026 and 26,312,842 shares at December 31, 2025 (after deducting treasury shares of 638,553 and 735,954, respectively), at stated capital amounts
Additional paid-in capital
Retained earnings
Accumulated other comprehensive (loss)
Total equity
Total liabilities and equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support